These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26178291)

  • 1. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
    Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C
    Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
    Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
    J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.
    Liu S; Lin SJ; Li G; Kim E; Chen YT; Yang DR; Tan MH; Yong EL; Chang C
    Endocr Relat Cancer; 2014 Jun; 21(3):R279-300. PubMed ID: 24623743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
    Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
    Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.
    Lin SJ; Lee SO; Lee YF; Miyamoto H; Yang DR; Li G; Chang C
    Carcinogenesis; 2014 Jun; 35(6):1399-406. PubMed ID: 24583925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
    Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C
    Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.
    Berlin A; Lalonde E; Sykes J; Zafarana G; Chu KC; Ramnarine VR; Ishkanian A; Sendorek DH; Pasic I; Lam WL; Jurisica I; van der Kwast T; Milosevic M; Boutros PC; Bristow RG
    Oncotarget; 2014 Nov; 5(22):11081-90. PubMed ID: 25415046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-PKcs Expression Is a Predictor of Biochemical Recurrence After Permanent Iodine 125 Interstitial Brachytherapy for Prostate Cancer.
    Molina S; Guerif S; Garcia A; Debiais C; Irani J; Fromont G
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):965-972. PubMed ID: 27113564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
    Gong P; Zhang T; He D; Hsieh JT
    Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of testicular nuclear receptor 4 in chemo-resistance of docetaxel in castration-resistant prostate cancer.
    Chen B; Yu S; Ding X; Jing C; Xia L; Wang M; Matro E; Rehman F; Niu Y; Li G; Chang C
    Cancer Gene Ther; 2014 Oct; 21(10):411-5. PubMed ID: 25104727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.
    Chen D; Chou FJ; Chen Y; Tian H; Wang Y; You B; Niu Y; Huang CP; Yeh S; Xing N; Chang C
    Cancer Lett; 2020 Dec; 495():100-111. PubMed ID: 32768524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
    Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C
    Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters.
    Marinescu IM; Rogg M; Spohn S; von Büren M; Kamps M; Jilg CA; Fountzila E; Papadopoulou K; Ceci L; Bettermann A; Ruf J; Benndorf M; Adebahr S; Zips D; Grosu AL; Schell C; Zamboglou C
    Radiat Oncol; 2022 Oct; 17(1):163. PubMed ID: 36199143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of N-acetylglucosaminyltransferase V enhances sensitivity of radiotherapy in human prostate cancer.
    Huang H; Chen W; Liu Q; Wei T; Zhu W; Meng H; Guo L; Zhang J
    Biochem Biophys Res Commun; 2014 Aug; 451(3):345-51. PubMed ID: 25117443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.
    Lin SJ; Yang DR; Wang N; Jiang M; Miyamoto H; Li G; Chang C
    Oncoscience; 2015; 2(2):142-50. PubMed ID: 25859557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.
    Lin SJ; Yang DR; Li G; Chang C
    Front Endocrinol (Lausanne); 2015; 6():78. PubMed ID: 26074876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer.
    Goto K; Oue N; Hayashi T; Shinmei S; Sakamoto N; Sentani K; Teishima J; Matsubara A; Yasui W
    Pathobiology; 2014; 81(4):190-8. PubMed ID: 25170626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TR2 and TR4 Orphan Nuclear Receptors: An Overview.
    Lin SJ; Yang DR; Yang G; Lin CY; Chang HC; Li G; Chang C
    Curr Top Dev Biol; 2017; 125():357-373. PubMed ID: 28527578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.
    Diallo JS; Aldejmah A; Mouhim AF; Péant B; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
    Clin Cancer Res; 2007 Dec; 13(23):7044-52. PubMed ID: 18056181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.